A movement is growing at Harvard Medical School to bring corporate influence over the curriculum into the open and under control.

The School received an "F" grade from the American Medical Students Association for its monitoring and control of drug industry money. Yale scored a "C", University of Pennsylvania an "A" and Stanford a "B".

From the New York Times report:

"David Tian, 24, a first-year Harvard Medical student, said: “Before coming here, I had no idea how much influence companies had on medical education. And it’s something that’s purposely meant to be under the table, providing information under the guise of education when that information is also presented for marketing purposes.”
...
no one disputes that many individual Harvard Medical faculty members receive tens or even hundreds of thousands of dollars a year through industry consulting and speaking fees. Under the school’s disclosure rules, about 1,600 of 8,900 professors and lecturers have reported to the dean that they or a family member had a financial interest in a business related to their teaching, research or clinical care. The reports show 149 with financial ties to Pfizer and 130 with Merck."

0 Comments

Dead tree version

ADVERTISMENT